Several GDF-15 agonists are undergoing early phase clinical trials including NNC0247-0829 and JNJ-9090/CIN-109
GLP-1 receptor agonists: European drug regulator asks makers for evidence of self-harm
Researchers exploring peptide science often seek reliable information about peptide compounds, quality standards, and sourcing considerations within Australia
When pH drops below 5.5, carboxyl groups (COOH) protonate, causing polymer contraction, which compresses internal pores and expels molecules (Tapponi et al., 2025)
At AyaFusion, peptide therapy is never about chasing outcomesits about matching the right tool to the right body at the right time
The implications extend beyond diabetes, with broad applications in oncology, neurodegenerative, and inflammatory diseases, potentially accelerating the development of new treatments